Original Query: ALL
Previous Study | Return to List | Next Study

Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass (Executive)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01373216
Recruitment Status : Completed
First Posted : June 14, 2011
Last Update Posted : February 2, 2016
Eli Lilly and Company
Information provided by (Responsible Party):
Martin Haluzik, Charles University, Czech Republic

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2014
  Study Completion Date : December 2014